Literature DB >> 10771008

Nicotine in an animal model of attention.

I P Stolerman1, N R Mirza, B Hahn, M Shoaib.   

Abstract

Studies in smokers have suggested that at least part of the improved psychomotor performance produced by nicotine is the result of an effect on attention. Many animal experiments have assessed the effects of nicotine and its antagonists on diverse types of learning and memory but relatively few have looked at it in tasks designed to assess attention. In a five-choice serial reaction time task (5-CSRTT), rats with restricted access to food were presented with an array of five holes; illumination of a randomly selected hole signalled that a nose-poke into it would be reinforced by food presentation. Initially, signal length and the inter-trial interval (ITI) were varied and the procedure was demonstrated to satisfy some criteria for a vigilance task. The effects of nicotine on deficits in performance induced by varying signal length and ITI were assessed. Under appropriate conditions, small doses of nicotine increased the percentage of correct responses (accuracy), decreased omission errors and reaction time, and increased anticipatory responses. Subsequently, the effects of varying the ITI were examined more extensively in a slightly modified task. Here, nicotine produced small but robust, highly significant dose-related increases in accuracy, as well as decreases in omission errors and reaction times. Nicotine also increased accuracy when light stimuli were presented in an unpredictable manner. The nicotine antagonist mecamylamine produced a modest deficit in reaction time only. It is concluded that appropriate doses of nicotine can produce robust improvements in performance of normal rats in an attentional task. The effect cannot be attributed easily to changes in sensory or motor capability, learning or memory and may provide the measures needed to investigate the neuropharmacological and neuroanatomical bases of the elusive attentional effect of nicotine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771008     DOI: 10.1016/s0014-2999(99)00886-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  43 in total

1.  Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.

Authors:  Amir H Rezvani; Marty Cauley; Hannah Sexton; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

2.  Comparative effects of different test day challenges on performance in the 5-choice serial reaction time task.

Authors:  Nurith Amitai; Athina Markou
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

3.  Low-dose nicotine facilitates spatial memory in ApoE-knockout mice in the radial arm maze.

Authors:  Ruby Sultana; Kiyoshi Ameno; Mostofa Jamal; Takanori Miki; Naoko Tanaka; Junichiro Ono; Hiroshi Kinoshita; Yu Nakamura
Journal:  Neurol Sci       Date:  2012-07-07       Impact factor: 3.307

4.  Smoking impacts on prefrontal attentional network function in young adult brains.

Authors:  Francesco Musso; Franziska Bettermann; Goran Vucurevic; Peter Stoeter; Andreas Konrad; Georg Winterer
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

Review 5.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 6.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

7.  Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats.

Authors:  Yoshihisa Kitamura; Erika Kanemoto; Misaki Sugimoto; Ayumi Machida; Yuka Nakamura; Nanami Naito; Hirotaka Kanzaki; Ikuko Miyazaki; Masato Asanuma; Toshiaki Sendo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-07       Impact factor: 3.000

8.  Nicotine does not enhance discrimination performance in a temporal bisection procedure.

Authors:  Ryan D Ward; Scott T Barrett; Robert N Johnson; Amy L Odum
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

Review 9.  Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Authors:  Y Chudasama; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

10.  Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition.

Authors:  Luyi Zhou; Miranda L Fisher; Robert D Cole; Thomas J Gould; Vinay Parikh; Pavel I Ortinski; Jill R Turner
Journal:  Neuropsychopharmacology       Date:  2017-11-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.